Abreos Biosciences Lands Seed Funding Round

  • Feed Type
  • Date
    6/29/2016
  • Company Name
    Abreos Biosciences
  • Mailing Address
    3550 General Atomics Ct G02 San Diego, CA 92121 USA
  • Company Description
    Abreos Biosciences is an early stage biotech company pioneering assays for detection of biologic drugs using its proprietary Veritope technology. Abreos develops laboratory-based and point-of-care assays that enable personalized dosing and counterfeit detection of these expensive drugs, such as therapeutic monoclonal antibodies.
  • Website
    http://www.abreos.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    Undisclosed
  • Transaction Round
    Seed
  • Proceeds Purposes
    Funds from the seed round are enabling Abreos to accelerate their commercialization plan, expand their marketing and business development teams, and establish major clinical research partnerships in the US and Europe.
  • M&A Terms
  • Venture Investor
    Triton Technology Fund

Trending on Xconomy